Dynavax Technologies (DVAX) Stock Price, Quote & News

Company Profile

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally. The company offers HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older; and CpG 1018, the adjuvant used in HEPLISAV-B. It also develops rF1V, a plague vaccine candidate in Phase 2 clinical trial; and Z-1018, an investigational vaccin...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 510 848 5100

Fax: 510 848 1327

Website: www.dynavax.com

Address:

2100 Powell Street, Suite 720, EmeryVille, United States

KWalzz Aug. 27 at 12:30 PM

$DVAX SI again lower, for the 7th time in a row lower than usual. whoever cares ...

1 · Reply

Buy_dvax100 Aug. 26 at 5:37 PM

$DVAX 🐎

0 · Reply

poorguy Aug. 26 at 3:25 PM

$DVAX DVAX has been like a strong horse locked in the barn. For days, shorts kept pulling hard on the leash, holding it back even though there was good news about its promising shingles trial. The horse grew restless, stamping the ground, waiting for its moment. And from today, it will finally kickthe door open and start running. With the strength it’s carrying, it looks ready to keep charging forward in the days and weeks ahead.

1 · Reply

KWalzz Aug. 26 at 9:21 AM

$DVAX to remember why DVAX fails #3.

0 · Reply

KWalzz Aug. 25 at 8:23 PM

$DVAX 9s coming here I fear...lets hope not.

0 · Reply

KWalzz Aug. 25 at 8:19 PM

$DVAX and one of its so-called "partners" ... someone recently spilled out nonsense about a DVAX VALN cooperation or similar bs... dont know who it was and didnt care... LMAO.

0 · Reply

VolumePrice Aug. 25 at 6:23 PM

$DVAX looks like DT sold shares after news to hold price down as part of their fight with BOD :) They should sell all their shares and get out since other shareholders are not supporting their agenda, lol

0 · Reply

Buy_dvax100 Aug. 25 at 4:44 PM

$DVAX Scottie do a little insider buying

0 · Reply

KWalzz Aug. 25 at 3:07 PM

$DVAX this guy is toxic it seems .. he owns 259000 VRDN shares and was fired as VRDN CEO (for the luck of VRDN), he bought 4000 VRDN shares in the open market before he was fired because the SP was going down sharply while he was CEO over there ... and now in a seemingly cynical move he buys lousy 3800 DVAX shares in the om and owns lousy 35004 DVAX shares in total ... unbelievable how DVAX management acts and that they still do not fire him ...

1 · Reply

martycar97 Aug. 25 at 2:05 PM

$DVAX Back to where we started…

0 · Reply

Dynavax's shingles vaccine shows similar immune response to GSK's shot in study

GSK

Aug 21, 2025, 8:00 AM EDT - 6 days ago

Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile

Aug 11, 2025, 8:41 AM EDT - 16 days ago

Dynavax Technologies: A Dip To Accumulate

Aug 7, 2025, 10:51 PM EDT - 19 days ago

Dynavax Technologies Corporation (DVAX) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:00 PM EDT - 19 days ago

Dynavax Reports Second Quarter 2025 Financial Results

Jul 29, 2025, 4:02 PM EDT - 4 weeks ago

Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

Jun 11, 2025, 12:14 PM EDT - 2 months ago

Dynavax elects all four of its nominees after Deep Track proxy fight

Jun 11, 2025, 11:01 AM EDT - 2 months ago

Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting

Jun 9, 2025, 8:30 AM EDT - 2 months ago

Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom

Jun 9, 2025, 7:30 AM EDT - 2 months ago

Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting

Jun 4, 2025, 4:59 PM EDT - 2 months ago

Dynavax Comments on Glass Lewis Recommendation

Jun 4, 2025, 9:27 AM EDT - 3 months ago

Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies

May 28, 2025, 4:10 PM EDT - 3 months ago

Dynavax to Present at William Blair's 45th Annual Growth Stock Conference

May 23, 2025, 6:12 PM EDT - 3 months ago

Deep Track Capital Comments on ISS Recommendation

May 23, 2025, 1:54 PM EDT - 3 months ago

ISS backs Dynavax directors in board fight with Deep Track Capital

May 23, 2025, 1:44 PM EDT - 3 months ago

Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees

May 21, 2025, 11:48 PM EDT - 3 months ago

Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking Good

May 15, 2025, 4:00 PM EDT - 3 months ago

Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting

May 12, 2025, 7:30 AM EDT - 3 months ago

Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value

May 7, 2025, 4:45 PM EDT - 3 months ago

Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum

May 6, 2025, 7:34 PM EDT - 4 months ago

Dynavax Technologies Corporation (DVAX) Q1 2025 Earnings Call Transcript

May 6, 2025, 4:01 PM EDT - 4 months ago

Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs

May 6, 2025, 8:00 AM EDT - 4 months ago

Deep Track Capital Releases Investor Presentation on Dynavax Technologies

May 1, 2025, 8:00 AM EDT - 4 months ago

Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits

Apr 29, 2025, 7:30 AM EDT - 4 months ago

Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy

Apr 22, 2025, 4:00 PM EDT - 4 months ago

Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025

Apr 21, 2025, 4:05 PM EDT - 4 months ago

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Apr 17, 2025, 7:15 AM EDT - 4 months ago

Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders

Apr 16, 2025, 8:00 AM EDT - 4 months ago

Deep Track Capital Comments on Dynavax Technologies' Rejection of Most Recent Settlement Offer

Apr 3, 2025, 5:40 PM EDT - 5 months ago

Dynavax Files Preliminary Proxy Statement

Mar 10, 2025, 8:00 AM EDT - 6 months ago

Deep Track Capital Sends Letter to Dynavax Technologies' Board of Directors

Mar 6, 2025, 6:00 AM EST - 6 months ago

Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase

Mar 3, 2025, 5:58 PM EST - 6 months ago

Dynavax Technologies: A Post-Earnings Assessment With Growing Market Share

Feb 25, 2025, 4:10 PM EST - 6 months ago

Dynavax to Participate in Upcoming Investor Conferences

Feb 20, 2025, 6:38 PM EST - 6 months ago

Dynavax Technologies Corporation (DVAX) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 4:01 PM EST - 6 months ago

Dynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Financial Guidance

Feb 19, 2025, 4:52 PM EST - 6 months ago

Dynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy

Feb 19, 2025, 9:00 AM EST - 6 months ago

Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies' Board of Directors at 2025 Annual Meeting

Feb 19, 2025, 8:04 AM EST - 6 months ago

Exclusive: Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors

Feb 11, 2025, 3:11 PM EST - 7 months ago

Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty

Feb 6, 2025, 5:42 PM EST - 7 months ago

Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025

Jan 27, 2025, 6:00 AM EST - 7 months ago

Dynavax Advances Board Refreshment Program

Jan 13, 2025, 9:00 AM EST - 8 months ago

Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights

Nov 26, 2024, 4:05 PM EST - 9 months ago

Dynavax to Present at the 7th Annual Evercore HealthCONx Conference

Nov 13, 2024, 6:36 PM EST - 10 months ago

Dynavax Technologies: What The Stock Buyback Means. What It Doesn't

Nov 11, 2024, 8:00 AM EST - 10 months ago

Dynavax Announces $100 Million Accelerated Share Repurchase Program

Nov 7, 2024, 7:46 PM EST - 10 months ago

Dynavax Technologies Corporation (DVAX) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:02 PM EST - 10 months ago

Dynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates

Nov 7, 2024, 4:01 PM EST - 10 months ago

Dynavax Announces $200 Million Share Repurchase Program

Nov 6, 2024, 1:10 PM EST - 10 months ago

Glancy Prongay & Murray LLP Announces Investigation of Dynavax Technologies Corporation (DVAX)

KWalzz Aug. 27 at 12:30 PM

$DVAX SI again lower, for the 7th time in a row lower than usual. whoever cares ...

1 · Reply

Buy_dvax100 Aug. 26 at 5:37 PM

$DVAX 🐎

0 · Reply

poorguy Aug. 26 at 3:25 PM

1 · Reply

KWalzz Aug. 26 at 9:21 AM

$DVAX to remember why DVAX fails #3.

0 · Reply

KWalzz Aug. 25 at 8:23 PM

$DVAX 9s coming here I fear...lets hope not.

0 · Reply

KWalzz Aug. 25 at 8:19 PM

$DVAX and one of its so-called "partners" ... someone recently spilled out nonsense about a DVAX VALN cooperation or similar bs... dont know who it was and didnt care... LMAO.

0 · Reply

VolumePrice Aug. 25 at 6:23 PM

0 · Reply

Buy_dvax100 Aug. 25 at 4:44 PM

$DVAX Scottie do a little insider buying

0 · Reply

KWalzz Aug. 25 at 3:07 PM

1 · Reply

martycar97 Aug. 25 at 2:05 PM

$DVAX Back to where we started…

0 · Reply

KWalzz Aug. 25 at 1:44 PM

$DVAX to remember why DVAX fails, 3800 shares purchase is ridiculous, this Myers is cynic-toxic ...

0 · Reply

AccuRoger Aug. 25 at 1:30 PM

$DVAX Open Market purchase by BOD Chair Myers. https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=319401665&type=HTML&symbol=DVAX&cdn=9f9495b472398bcc50cd9e4a36e6fab9&companyName=Dynavax+Technologies+Corporation&formType=4&formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&dateFiled=2025-08-25

2 · Reply

KWalzz Aug. 24 at 5:15 PM

$DVAX to remember why DVAX fails.

0 · Reply

Chalutz Aug. 24 at 3:15 AM

$DVAX Deep Track only lightened up, they didn’t liquidate. Why keep such a big position under circumstance. BTW I hate this stock

1 · Reply

Chalutz Aug. 24 at 3:04 AM

$DVAX Totally unfounded speculation but is there something going on with GS’s PT. They were/are DVAX’s IBs? Are they holding down price for a potential BO? Meyer’s and BOD aren’t going to survive. How are they going to get paid before being ousted, sell the Co? As I said baseless speculation. DYOR AND MYODs! I‘m long and hate this stock! GLTA!

0 · Reply

Dvax2theMoon Aug. 24 at 12:14 AM

$DVAX why would DT sell right after “positive” news ??

0 · Reply

KWalzz Aug. 23 at 4:40 PM

$DVAX although I did not know that Deep Track was about to sell 2 million shares in DVAX this week I had a feeling to give up some holdings and invest in $VKTX ... what a coincidence. But I think VKTX has much more future. BULLISH for VKTX!

2 · Reply

KWalzz Aug. 23 at 4:36 PM

$DVAX this is a clear signal here. sorry and sad, but this company will not see much in the next years with Spencer & Myers staying at their positions. https://investors.dynavax.com/node/21821/html

0 · Reply

KWalzz Aug. 23 at 4:30 PM

$DVAX thanks for the update, sorry to see them go. but it is better to go when you do not see a future. I don't see much of a future here, too.

0 · Reply

AccuRoger Aug. 23 at 1:51 PM

$DVAX DeepTrack sold over two million shares this week. Tutes control this share price. Reality is a hard pill to swallow. I choose the blue pill. https://www.ainvest.com/news/deep-track-biotechnology-master-fund-sells-2-1m-dvax-shares-days-2508/

0 · Reply

HRHKK Aug. 23 at 12:48 PM

$DVAX Deep Track just sold over 2 million shares

1 · Reply

SwapTradingAdvisors Aug. 23 at 11:26 AM

$DVAX Dynavax Technologies Corporation is facing vaccine adjuvant competition and partnership dependencies

0 · Reply

Market Cap	1.22B
Revenue (ttm)	277.25M
Net Income (ttm)	27.31M
EPS (ttm)	N/A
PE Ratio	52.50
Forward PE	N/A
Profit Margin	9.85%
Debt to Equity Ratio	0.08

Volume	2,279,600
Avg Vol	1,717,784
Day's Range	N/A - N/A
Shares Out	117.27M
Stochastic %K	15%
Beta	1.09
Analysts	Sell
Price Target	$22.67